News Sanofi

Equities

SAN

FR0000120578

Market Closed - Euronext Paris Other stock markets 11:37:39 2024-04-19 am EDT			After market 03:59:59 pm
86.89 ^EUR	+1.95%		86.6	-0.33%

08:00pm	Sector Update: Health Care Stocks Rise Friday Afternoon	MT
04:11pm	Global markets live: P&G, Amex, Blackstone, Apple, Tesla...

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Rise Friday Afternoon	02:00pm	MT
Global markets live: P&G, Amex, Blackstone, Apple, Tesla...	10:11am
Sector Update: Health Care Stocks Steady Pre-Bell Friday	09:16am	MT
Sector Update: Health Care	08:58am	MT
Sanofi Planning to Restructure US Commercial Operations for Vaccines; Job Losses Likely	05:46am	MT
Sanofi Reportedly Planning to Restructure US Commercial Operations for Vaccines; Job Losses Likely	Apr. 18	MT
Sanofi to overhaul US operations of vaccines, cut jobs	Apr. 18	RE
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	Apr. 18	MT
SANOFI : JP Morgan reiterates its Neutral rating	Apr. 18	ZD
Sanofi Announces Quebec's INESSS Recommends BEYFORTUS® for Prevention of RSV for All Infants 8 Months of Age and Younger	Apr. 18	CI
IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets	Apr. 17	MT
BeiGene to Award Shares Worth $15 Million to 11 Directors	Apr. 17	MT
Sanofi's Frexalimab Reduces Disease Activity in Multiple Sclerosis Patients in Phase 2 Trial	Apr. 17	MT
Sanofi: new positive phase II results in MS	Apr. 17	CF
The 2023 Pharmaceutical Patent Review	Apr. 17	AQ
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis	Apr. 17	GL
INNATE PHARMA ANNOUNCES ADVANCEMENT OF SANOFI-DEVELOPED NK CELL ENGAGER SAR443579/IPH6101 PROGRESSING TO PHASE 2 FOR BLOOD CANCER PATIENTS	Apr. 16	AQ
IDT Australia Signs Master Service Agreement with Sanofi	Apr. 15	MT
Sanofi: progress in hematology trial	Apr. 15	CF
Innate Pharma: progress in hematology trial	Apr. 15	CF

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANOFI : Looking beyond the quarterly miss, Sanofi remains an attractive bet

February 01, 2024 at 11:26 am EST

Sanofi Sees Trend for Years of Steady Growth: CFO

February 03, 2023 at 03:56 pm EST